Factors Driving Willingness to Receive Influenza, COVID-19, and Combination Influenza/COVID-19 Vaccines Among Health Care Workers
| Registry | NCT07871448 |
|---|---|
| Status | Not yet recruiting |
| Study type | Observational |
| Enrollment | 550 (Estimated) |
| Sponsor | George Washington University (Other); collaborators: Sanofi Pasteur, a Sanofi Company |
| Conditions | Influenza, COVID-19, Vaccination Willingness |
| Interventions | Survey (Other) |
| Dates | start 2026-10-01 (estimated), primary completion 2027-09-30 (estimated), completion 2028-04-01 (estimated), first posted 2026-10-13, last updated 2026-10-13 |
| Locations | 2 sites in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Influenza All trials for COVID-19 All trials of Survey
This study addresses a critical evidence gap relevant to implementation strategies for combination vaccines in health care settings. This study will specifically investigate healthcare worker (HCWs) attitudes around and willingness to receive combination influenza/COVID-19 vaccines. Findings will identify determinants of hesitancy and acceptance among HCWs and support effective rollout strategies and communication approaches. Cross-sectional surveys and qualitative interviews will be conducted with healthcare workers to characterize HCW willingness to be vaccinated and to identify demographic, attitudinal, and structural predictors of vaccination.
This study uses a sequential explanatory mixed-methods design. The first phase utilizes a cross-sectional, multi-site electronic survey. The quantitative survey will characterize willingness of approximately 550 HCWs to receive a combination influenza/COVID-19 vaccine and to identify demographic, attitudinal, and structural predictors of vaccination. Participants will complete a one-time REDCap survey (approximately 20-30 minutes).
In the second phase, a subset of 10-20 HCWs will be invited to participate in qualitative interviews that will be used to interpret and elaborate on quantitative findings. Specifically, the qualitative analysis allows for exploration of the nuanced rationale behind reported willingness to vaccinate, gives additional context to latent constructs identified in factor analysis, and identifies communication preferences that are not adequately captured by closed-ended questions. Integration will occur at the interpretation stage: quantitative results will inform purposive sampling for the qualitative phase, and qualitative themes will be used to contextualize and explain patterns observed in the quantitative analysis. A joint display table will be used in reporting to show how qualitative findings confirm, extend, or challenge quantitative results.
Sex: All, ages: 18 Years to 89 Years, accepts healthy volunteers
Inclusion Criteria: * Age 18-89 years old * Currently employed or enrolled as a student at GWU, GW MFA or CNH * Eligible for institutional influenza vaccination * Able to complete the survey in English Exclusion Criteria: * On long-term leave at the time of survey launch * Contractors without institutional email access * Contraindication to receiving influenza vaccination * Contraindication to receiving COVID-19 vaccination
| Facility | City | Country | Status |
|---|---|---|---|
| Children's National Hospital | Washington D.C., District of Columbia | United States | |
| George Washington University | Washington D.C., District of Columbia | United States |